Meeting
2019 Genitourinary Cancers Symposium
Pilot study of dual imaging with 89Zr-IAB2M and 68Ga-PSMA-11 PET/CT prior to prostatectomy.
Authors
Muhammad Junaid Niaz
Weill Cornell Medical College, New York, NY
Muhammad Junaid Niaz , Yuliya Jhanwar , Thomas Flynn , Shankar Vallabhajosula , Francesca Khani , Brian D. Robinson , Scott T. Tagawa , Neil Harrison Bander , Douglas Scherr
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Clinical Trial Registration Number
NCT03675451
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 90)
DOI
10.1200/JCO.2019.37.7_suppl.90
Abstract #
90
Poster Bd #
E14
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer.
First Author: Romain Schollhammer Sr.
Poster
2015 ASCO Annual Meeting
PET imaging with 68Gallium-labelled ligand of prostate-specific membrane antigen (68Ga-HBED-PSMA) for staging of biochemical recurrent prostate cancer after radical prostatectomy.
First Author: Tobias Maurer
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2024 ASCO Genitourinary Cancers Symposium
SABRE: Assessment of safety and efficacy of 64Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.
First Author: Luke T. Nordquist